Hes from big pharma....
FDA names new head of tobacco products center - The Herald Dispatch
FDA names new head of tobacco products center - The Herald Dispatch
from that article it seems that he will be more about the SCIENCE of everything and not the public opinion and lobbyists...
im cautiously optimistic about a new guy...
A little research here's a broken link to an article he wrote in 2004 for APA american Psychological Association(ok I couldn't figure out how to break the link, just google "Mitch Zeller" e-cig It sounds like he wants a bunch of research before anything is allowed and he specifically scoffs at the lower incidence of lung cancer in Sweden due to Snu's.
Here's a quote
A group of scientists has been calling for a major effort at reducing the amount of nicotine in cigarettes so that, over time, a non-addictive level of nicotine would be reached--and cigarettes would no longer be addictive. Study after study has shown that if such were the case, about 80 to 90% of smokers would quit. And teens who experimented with truly low-nicotine cigarettes wouldn’t get hooked—unlike the “light” cigarette scandal, where the supposedly safer cigarettes may actually have turned out to be more dangerous because they forced smokers to smoke more in order to get the desired effect. Dr. Hatsukami and five other prominent nicotine experts contend that extremely low-nicotine cigarettes do not cause smokers to smoke more, “because it is harder to compensate for very low nicotine intake,” according to Hatsukami. Especially if there are no high-nicotine alternatives for sale—legally, at least. Mitch Zeller, who along with Hatsukami, co-chairs the National Cancer Institute’s Tobacco Harm Reduction Network, painted this picture: “Imagine a world where the only cigarettes that kids could experiment with would neither create nor sustain addiction."
Sounds like he thinks europes limit to 4 mg liquid is a good idea.
Sounds to me like he wants to take the nicotine out of ciggs to give glaxo more customers for their nicotine.
here
There are two approaches to regulating tobacco use: one that says there's no safe way to use tobacco and pushes for people to quit above all else. Others embrace the idea that lower-risk alternatives like smokeless tobacco and other nicotine delivery systems like gum or even electronic cigarettes can help improve overall health.
The 2009 law lays out the possibility for both, prescribing a scientific approach to improve public health. But the challenge and opportunity is for the agency to "come up with a comprehensive nicotine regulatory policy aimed at shifting tobacco users down the continuum from the most harmful to the least harmful," Zeller said, who also co-chairs the National Cancer Institute's Tobacco Harm Reduction Network.
and here
The nation's largest cigarette maker, Marlboro manufacturer Altria Group Inc., said, "We believe that, under Dr. Deyton's leadership, the Center for Tobacco Products has been focused on establishing a science- and evidence-based approach to regulating tobacco products, and we will continue to engage with the Agency to further this regulatory focus on science and evidence."
Zeller, who served as associate commissioner and director of agency's Office of Tobacco Programs from 1993 until 2000, is currently an executive with Pinney Associates, a Maryland-based pharmaceutical consulting firm that does work for GlaxoSmithKline, the leading seller of nicotine-replacement therapy products.
Because he was appointed the head of the agency which is soon to decide the ultimate fate of electronic cigarettes.idk why you are worried about what they do to tobacco, we don't use tobacco...we use nicotine.
Well, ask and you shall receive...This is extremely important news, and I'd love to hear what Bill Godshall has to say about him.
Nicorette's new front man.From The Article: Zeller, who served as associate commissioner and director of agency's Office of Tobacco Programs from 1993 until 2000, is currently an executive with Pinney Associates, a Maryland-based pharmaceutical consulting firm that does work for GlaxoSmithKline, the leading seller of nicotine-replacement therapy products.